MoonLake Immunotherapeutics (MLTX) Q4 2022 Earnings

1MarExpected
May 22
Aug 22
Nov 22
Q4 2022
-0.54
-0.36
-0.18
0

Details

Expected EPS
-0.34
Actual EPS
0
Surprise EPS
0.34
Surprise Percent
+100%

Description

MoonLake Immunotherapeutics (MLTX) will report earnings of for Q4 2022 on March 01, 2023.

0 Comments

Share your thoughts